Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Century 21 Returns to NYC After Closing Early in Pandemic
Century 21 was a long-time staple for bargain shopping in Manhattan when it went belly up in 2020 at the height of the COVID-19 pandemic. Now, as of last week, the store has reopened and some locals see it as a sign of an economic recovery in New York City.
Load More